Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study: Radiofrequency Ablation of Locally Advanced Pancreatic Cancer

NCT01628458 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT01628458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01628458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study: Radiofrequency Ablation of Locally Advanced Pancreatic Cancer
Lead sponsor
UMC Utrecht
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2012
Completion date
November 30, 2014
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced pancreatic cancer